Oxidative and Excitatory Mechanisms of Developmental Neurotoxicity: Transcriptional Profiles for Chlorpyrifos, Diazinon, Dieldrin, and Divalent Nickel in PC12 Cells by Slotkin, Theodore A. & Seidler, Frederic J.
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 4 | April 2009  587
Research
A wide variety of toxicants elicit cell dam-
age through their shared ability to produce 
oxidative stress (Gitto et al. 2002; Gupta 
2004; Ohtsuka and Suzuki 2000; Olanow 
and Arendash 1994). The brain is especially 
vulnerable because it has a high rate of oxy-
gen consumption, combined with a mem-
brane lipid composition that is enriched in 
oxidizable polyunsaturated fatty acids (Gupta 
2004). The developing brain is even more sen-
sitive because it has lower reserves of protec-
tive enzymes and anti  oxidants (Gupta 2004) 
and has a higher ratio of neurons to glia, the 
cells that ordinarily protect neurons from 
oxidative molecules (Tanaka et al. 1999), 
while at the same time facing the increased 
metabolic demand associated with growth. 
Further, the fact that fetal arterial blood has 
substantially lower O2 concentrations means 
that the fetal brain is already hypoxic relative 
to that of a newborn or adult (Faber et al. 
1985; Lagercrantz and Slotkin 1986), thus 
reducing the margin of safety for any agent 
that compromises oxidative metabolism. The 
combination of these factors explains why 
many environmental contaminants elicit 
oxidative stress within the developing brain 
(Henderson et al. 1999; Jett and Navoa 2000; 
Kern and Jones 2006; Mulholland et al. 2005; 
Pardo and Eberhart 2007; Sinha et al. 2006; 
Tata and Yamamoto 2007); indeed, this may 
provide a mechanism by which diverse com-
pounds converge on common sets of neuro-
developmental dis  orders, such as autism (Kern 
and Jones 2006; Pardo and Eberhart 2007).
Exposure of the human population 
to organophosphate pesticides is ubiqui-
tous (Barr et al. 2005; Bouvier et al. 2005; 
Casida and Quistad 2004), and these com-
pounds are undergoing restriction because 
of their propensity to produce develop-
mental neuro  toxicity [U.S. Environmental 
Protection Agency (EPA) 2000, 2002, 2006]. 
Chlorpyrifos, diazinon, and other organophos-
phates produce oxidative stress in the develop-
ing brain, leading to shifts in expression and 
function of anti  oxidant genes, and accord-
ingly, anti  oxidant therapy can offset some of 
the damage (Bagchi et al. 1995; Giordano 
et al. 2007; Jett and Navoa 2000; Qiao et al. 
2005; Slotkin et al. 2007a; Slotkin and Seidler 
2007). Nevertheless, it is increasingly clear 
that the various organophosphates do not pro-
duce the same patterns of neuro  developmental 
damage or behavioral deficits, in part 
because they differ in other mechanisms that 
contribute to the net adverse outcomes (Pope 
1999; Roegge et al. 2008; Slotkin 1999, 2004, 
2005; Slotkin et al. 2006a, 2008a, 2008b, 
2008c, 2009; Slotkin and Seidler 2007, 2008; 
Timofeeva et al. 2008a, 2008b). The partici-
pation of these additional mechanisms means 
that, although related compounds may pro-
duce similar degrees of oxidative stress, the 
cellular reactions to that stress may end up 
being substantially different, such that for 
the same degree of initial damage, the out-
comes may be worse for particular agents. In 
the present study, we tested that hypothesis 
by examining the transcriptional responses 
to chlor  pyrifos and diazinon for the various 
cellular targets involved in the response to 
oxidative stress: catalase (cat), the isoforms 
of superoxide dismutase (sod), glutathione 
synthase (gss), glutathione reductase (gsr), the 
family of glutathione peroxidases (gpx), the 
genes for the cytoplasmic (α, µ, ω, π, θ) gluta-
thione S-transferases (gst), the microsomal and 
mitochondrial glutathione S-transferases (mgst, 
gst13-13), and the glutathione S-transferase 
yc2 subunit. In addition, we examined one 
of the major, indirect mechanisms by which 
organophosphates produce oxidative stress, 
namely, their actions on the function and 
expression of ionotropic glutamate receptors 
(Damodaran et al. 2006; Gupta 2004), which 
mediate excitotoxic cell death in the develop-
ing brain, including that evoked by hypoxia 
(Choi and Rothman 1990). We assessed 
expression of the AMPA receptor family (gria), 
δ-subunits (grid), kainate receptors (grik), 
NMDA (N-methyl d-aspartate) receptors 
(grin), and their associated glutamate-binding 
protein (grina). By way of contrast, we also 
assessed the metabotropic glutamate receptors 
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(grm), which are not involved in excito  toxicity. 
For reference, Table 1 lists all genes tested, 
with their full names and GenBank accession 
numbers (National Center for Biotechnology 
Information 2008). 
In addition to comparing the effects of 
chlorpyrifos with those of diazinon, we evalu-
ated two developmental neurotoxicants from 
different classes: dieldrin, an organochlorine 
pesticide, and divalent nickel (Ni2+). Both 
of these represent significant environmental 
concerns because like the organophosphates, 
they appear on the registry of Superfund 
chemicals (National Library of Medicine 
2006). Although dieldrin acts primarily by 
blocking GABAA receptors (Brannen et al. 
1998; Liu et al. 1998), it also elicits oxida-
tive stress akin to that of the organophos-
phates (Kitazawa et al. 2001, 2003; Slotkin 
et al. 2007b) and produces fetal brain damage 
(Uzoukwu and Sleight 1972). Ni2+ is found in 
the fetal brain in concentrations up to 2 µg/g, 
similar to lead (Casey and Robinson 1978), 
and, like lead, interferes with the gating of 
calcium during neuro  differentiation (Benters 
et al. 1996; Nikodijevic and Guroff 1992). 
In contrast to the other agents, Ni2+ does not 
elicit oxidative stress in developing neuronal 
cells (Slotkin et al. 2007b), and in fact, it shifts 
cellular redox status toward reduction, likely 
because it can donate electrons to form higher 
valence states (Slotkin et al. 2007b).
Because we wanted to compare the tran-
scriptional responses inherent to each com-
pound, we needed to avoid the confounds 
of pharmaco  kinetic differences or effects on 
the maternal–fetal unit. Accordingly, we 
studied PC12 cells, a widely accepted in vitro 
model for neuronal development (Teng and 
Greene 1994) that has already been validated 
to reproduce the mechanisms and outcomes 
found after in vivo exposures of develop-
ing rats to organophosphates (Bagchi et al. 
1995, 1996; Crumpton et al. 2000a, 2000b; 
Das and Barone 1999; Flaskos et al. 1994; 
Jameson et al. 2006, 2007; Li and Casida 
1998; Nagata et al. 1997; Qiao et al. 2001, 
2005; Slotkin et al. 2007a, 2007b, 2008d, 
2008e; Song et al. 1998; Tuler et al. 1989). 
When nerve growth factor (NGF) is added 
to the culture medium, PC12 cells begin to 
differentiate, forming neuritic projections and 
acquiring electrical excitability and neuronal 
phenotypes (Fujita et al. 1989; Song et al. 
1998; Teng and Greene 1994). The effects on 
neuro  differentiation in PC12 cells have been 
characterized previously for each of the four 
agents studied here (Qiao et al. 2001; Slotkin 
et al. 2007b; Slotkin and Seidler 2008, 2009), 
providing the necessary end points with which 
to interpret transcriptional responses. Finally, 
we compared effects in the undifferentiated 
and differentiating states for chlorpyrifos, 
as well as evaluating temporal responses for 
chlorpyrifos, diazinon, dieldrin, and Ni2+, so 
as to explore the role of critical developmental 
periods for vulnerability to oxidative stress 
and excitotoxicity.
Materials and Methods
Cell cultures. Because of the clonal instabil-
ity of the PC12 cell line (Fujita et al. 1989), 
we performed the experiments on cells that 
had undergone fewer than five passages. As 
described previously (Qiao et al. 2003; Song 
et al. 1998), we seeded PC12 cells (American 
Type Culture Collection, 1721-CRL; 
obtained from the Duke Comprehensive 
Cancer Center (Durham, NC) onto poly-d-
lysine–coated plates in RPMI-1640 medium 
(Invitrogen, Carlsbad, CA) supplemented 
with 10% inactivated horse serum (Sigma 
Chemical Co., St. Louis, MO), 5% inacti-
vated fetal bovine serum (Sigma), and 50 µg/
mL penicillin streptomycin (Invitrogen). 
Incubations were carried out with 7.5% CO2 
at 37°C, standard conditions for PC12 cells. 
To initiate neuro  differentiation (Jameson et al. 
2006; Slotkin et al. 2007b; Teng and Greene 
1994) 24 hr after seeding, the medium was 
Table 1. Gene names and Genbank accession numbers.
Gene symbol  Gene name  GenBank accession no.
cat  catalase  NM_012520
gpx1  glutathione peroxidase 1  NM_030826
gpx2  glutathione peroxidase 2  BQ196649
gpx3  glutathione peroxidase 3  AI172411
gpx4  glutathione peroxidase 4  NM_017165
gpx6  glutathione peroxidase 6  NM_147165
gria1  glutamate receptor, ionotropic AMPA 1  NM_031608
gria2  glutamate receptor, ionotropic AMPA 2  NM_017261
gria3   glutamate receptor, ionotropic AMPA 3  NM_032990
gria4  glutamate receptor, ionotropic AMPA 4  NM_017263
grid2  glutamate receptor, ionotropic δ1  NM_024379
grik1  glutamate receptor, ionotropic kainate 1  AI111480
grik2  glutamate receptor, ionotropic kainate 2  NM_019309
grik3  glutamate receptor, ionotropic kainate 3  NM_181373
grik4  glutamate receptor, ionotropic kainate 4  NM_012572
grik5  glutamate receptor, ionotropic kainate 5  NM_017262
grin1  glutamate receptor, ionotropic N-methyl-d-aspartate 1  NM_017010
grin2a  glutamate receptor, ionotropic N-methyl-d-aspartate 2a  NM_012573
grin2b  glutamate receptor, ionotropic N-methyl-d-aspartate 2b  NM_012574
grin2d  glutamate receptor, ionotropic N-methyl-d-aspartate 2d  NM_022797
grin3a  glutamate receptor, ionotropic N-methyl-d-aspartate 3a  AF061945
grin3b  glutamate receptor, ionotropic N-methyl-d-aspartate 3b  NM_133308
grina  glutamate receptor, ionotropic N-methyl-d-aspartate-associated protein  NM_153308
grm1  glutamate receptor, metabotropic 1  NM_017011
grm2  glutamate receptor, metabotropic 2  XM_343470
grm3  glutamate receptor, metabotropic 3  M92076
grm4  glutamate receptor, metabotropic 4  NM_022666
grm5  glutamate receptor, metabotropic 5  NM_017012
grm6  glutamate receptor, metabotropic 6  NM_022920
grm7  glutamate receptor, metabotropic 7  NM_031040
grm8  glutamate receptor, metabotropic 8  NM_022202
gsr  glutathione reductase  NM_053906
gss  glutathione synthetase  NM_012962
gst13-13  glutathione S-transferase, mitochondrial  NM_181371
gsta2  glutathione S-transferase, α2  BQ199390
gsta4  glutathione S-transferase, α4  XM_217195
gstm1  glutathione S-transferase, µ1  NM_017014
gstm2  glutathione S-transferase, µ2  NM_177426
gstm3  glutathione S-transferase, µ3  NM_031154
gstm4  glutathione S-transferase, µ4  NM_020540
gstm5  glutathione S-transferase, µ5  NM_172038
gstm6  glutathione S-transferase, µ6  XM_215682
gsto1  glutathione S-transferase, ω1  NM_001007602
gsto2  glutathione S-transferase, ω2  NM_001012071
gstp2  glutathione S-transferase, π2  NM_138974
gstt1  glutathione S-transferase, θ1  NM_053293
gstt2  glutathione S-transferase, θ2  NM_012796
gstt3  glutathione S-transferase, θ3  XM_574740
mgst1  microsomal glutathione S-transferase 1  NM_134349
mgst2  microsomal glutathione S-transferase 2  XM_215562
mgst3  microsomal glutathione S-transferase 3  XM_213943
sod1  superoxide dismutase 1  NM_017050
sod2  superoxide dismutase 2  AI235842
sod3  superoxide dismutase 3  NM_012880
yc2  glutathione S-transferase yc2 subunit  NM_001009920Mechanisms of developmental neurotoxicants
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changed to include 50 ng/mL of 2.5S murine 
NGF (Invitrogen). Along with the NGF, we 
added 30 µM of the test agent: chlorpyrifos 
(Chem Service, West Chester, PA), diazinon 
(Chem Service), dieldrin (Chem Service), 
or NiCl2 (Sigma). We chose this concentra-
tion from earlier studies that demonstrated 
adverse effects on differentiation of PC12 cells 
without outright cyto  toxicity (Jameson et al. 
2007; Qiao et al. 2001; Slotkin et al. 2007b, 
2008d). Because of the limited water solubil-
ity of the three insecticides, we dissolved these 
agents in DMSO (final concentration, 0.1%), 
which was also added to the control cultures 
and to cultures containing NiCl2; this concen-
tration of DMSO has no effect on PC12 cell 
growth or differentiation (Qiao et al. 2001, 
2003; Song et al. 1998). We examined cul-
tures 24 and 72 hr after commencing expo-
sure, with five to eight independent cultures 
evaluated for each treatment at each time 
point. We used two time points so we could 
evaluate changes in gene expression regardless 
of whether the mRNA for a given gene has a 
rapid turnover (and hence can rise rapidly) or 
a slower turnover that would require a longer 
period to show corresponding increases or 
decreases. For chlorpyrifos, we evaluated the 
effects both on undifferentiated cells and dur-
ing NGF-induced differentiation, whereas for 
the other agents, we studied only the effects 
during differentiation.
Microarray determinations. In the pres-
ent study, we performed mRNA isolation, 
preparation of cDNA, conversion to cRNA 
incorporating cyanine-3 (reference RNA) or 
cyanine-5 (sample RNA), verification of RNA 
purity and quality, hybridization to the micro-
arrays, washing, and scanning as described 
previously (Slotkin et al. 2007c, 2008d; 
Slotkin and Seidler 2007). The mRNA used 
for the reference standard was created by 
pooling aliquots from each of the samples 
in the study. Similarly, array normalizations 
and error detection were carried out using 
procedures described previously (Slotkin et al. 
2007c, 2008d; Slotkin and Seidler 2007). 
We used Agilent Whole Rat Genome Arrays 
(Agilent Technologies, Palo Alto, CA), type 
G4131A for the studies of chlorpyrifos in 
undifferentiated and differentiating cells, and 
type G4131F for the studies of diazinon, diel-
drin, and Ni2+ in differentiating cells. The 
two chips contain exactly the same sequences, 
but the latter has a lower detection threshold; 
however, all the genes reported here passed 
the quality control filters with both arrays.
For many of the genes, the arrays contain 
multiple probes for the same gene and/or rep-
licates of the same probe in different locations 
on the chip, and we used these to verify the 
reliability of values and the validity of the 
measures on the chip. To avoid artificially 
inflating the number of positive findings, we 
limited each gene to a single set of values, 
selecting those obtained for the probe show-
ing the smallest intragroup variance. We used 
the other values for that gene only to corrobo-
rate direction and magnitude of change. We 
also validated the readings on the arrays with 
duplicate arrays for selected samples (Slotkin 
et al. 2007c; Slotkin and Seidler 2007).
Statistical procedures. Because of the 
requirement to normalize the data across arrays 
and within each gene, the absolute values for a 
given gene are meaningless, so only the relative 
differences between treatments can be com-
pared. Accordingly, we present results as means 
and SEs of the percent change from control 
values to allow for visual comparison of the 
effects across families of genes. However, sta-
tistical comparisons were based on the actual 
ratios (log-transformed, because the data are 
ratios) rather than the percent change.
Our design involved multiple planned 
comparisons of four agents at two time 
points, as well as the effects of one agent 
(chlor  pyrifos) in undifferentiated versus dif-
ferentiating states. It was therefore important 
to consider the false-positive rate and to pro-
tect against the increased probability of type 
1 errors engendered by repeated testing of the 
same database. Accordingly, before looking at 
effects on individual genes, we performed a 
global analysis of variance (ANOVA) incor-
porating all the variables in a single compari-
son: treatment, time, and all genes. We then 
carried out lower-order ANOVAs on sub-
divisions of the data set as permitted by the 
interactions of treatment with the other vari-
ables. We evaluated differences for individual 
treatments for a specified gene at a single time 
point with Fisher’s protected least significant 
difference. However, for a given gene that 
showed no inter  action of treatment with 
other variables (time, differentiation state), we 
report only the main treatment effect with-
out subtesting effects at a single time point. 
We considered treatment effects significant at 
p < 0.05 (two-tailed, because we were inter-
ested in both increases and decreases in gene 
expression). Finally, concordance of patterns 
of effects between different agents was evalu-
ated by linear regression analysis.
In addition to these parametric tests of 
the direction and magnitude of changes in 
gene expression, we evaluated the incidence 
of significant differences compared with the 
predicted false-positive rate, using Fisher’s 
exact test, applying a one-tailed criterion of 
p < 0.05, because only an increase above the 
false-positive rate would be predicted; at the 
criterion of p < 0.05, 1 gene of every 20 tested 
can be expected to show a difference at random. 
Finding a significant decrease in the incidence 
of detected differences relative to the false-
positive rate would be biologically implausible 
and statistically meaningless.
Results
We compared the effects on undifferentiated 
versus differentiating cells with only one agent 
(chlorpyrifos), so we performed two sets of 
global statistical tests. For chlorpyrifos, the 
multivariate ANOVA incorporated the factors 
of treatment, differentiation state, time, and 
gene and identified interactions of treatment 
× gene (p < 0.0001), treatment × differentia-
tion state × gene (p < 0.0001), and treatment 
× time × state × gene (p < 0.03). Because of the 
strong interaction with differentiation state, we 
then subdivided the results to isolate the effects 
on undifferentiated and differentiating cells 
and identified significant effects in both states: 
undifferentiated, treatment × gene (p < 0.0001); 
differentiating, treatment × time (p < 0.04), 
treatment × gene (p < 0.0001), and treatment 
× time × gene (p < 0.05). Chlorpyrifos expo-
sure evoked significant changes in the expres-
sion of 40 of the total of 59 genes, compared 
with an expected false-positive rate of only 
3 genes (p < 10–14), and the same was true for 
the separate analyses of undifferentiated cells 
(24 of 59 genes, p < 10–7) and differentiating 
cells (34 of 59 genes, p < 10–9); in addition, the 
incidence of changes in differentiating cells was 
significantly greater than in the undifferenti-
ated state (p < 0.05). In light of the significant 
ANOVA interaction terms, we separated data 
according to pathway groups and then per-
formed lower-order tests for each gene.
For the study of diazinon, dieldrin, 
and Ni2+ conducted in differentiating cells, 
global ANOVA (factors of treatment, gene, 
time) identified a main effect of treatment 
(p < 0.0001) and interactions of treatment × 
time (p < 0.02), treatment × gene (p < 0.0001), 
and treatment × time × gene (p < 0.0001). Of 
the 59 total genes, we found significant differ-
ences for 44 (p < 10–15 vs. the predicted false-
positive rate). This was also true for each agent 
considered individually: diazinon, 32 genes, 
p < 10–10; dieldrin, 26 genes, p < 10–8; Ni2+, 
27 genes, p < 10–8. In light of the inter  actions 
of treatment with the other variables, we 
divided the data into the separate treatments 
for presentation, grouping the genes by path-
way and evaluating the effects on each gene.
Effects of chlorpyrifos in undifferentiated 
cells. Exposure of undifferentiated PC12 cells 
to chlorpyrifos for 24 or 72 hr had significant 
but modest effects on genes mediating anti-
oxidant responses and glutathione metabo-
lism. Although cat expression was unaffected, 
all three sod subtypes showed small but signifi-
cant down-regulation (Figure 1A). Neither gss 
nor gsr was affected, but two out of the six gpx 
genes showed significant up-regu  lation. The 
genes encoding the glutathione S-transferases 
likewise showed statistically significant 
changes in response to chlorpyrifos exposure, 
but the magnitude of effect did not exceed 
20% (Figure 1B). In general, the main effect Slotkin and Seidler
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was up-regulation (gsta4, gstm1, gstm2, gsto1, 
gstt2, mgst2, gst13-13), with the exception of 
yc2, which showed a decrement.
In contrast, we identified widespread and 
robust effects of chlorpyrifos on the gene family 
for ionotropic glutamate receptors (Figure 1C). 
We found consistent increases for gria1, grik4, 
grik5, grin3a, and grina and persistent decreases 
for gria2, gria4, and grik2. In addition, some 
genes showed transient effects, with increases 
(gria3, grik3) or decreases (grin2a) after 24 hr 
of exposure that waned by 72 hr. We did not 
see these effects for the metabotropic glutamate 
receptors, none of which showed significant 
effects of chlorpyrifos in undifferentiated cells 
(Figure 1D).
Antioxidant genes in differentiating cells. 
Compared with the effects on undifferenti-
ated PC12 cells, chlorpyrifos exposure dur-
ing differentiation elicited a greater overall 
response for the genes involved in antioxidant 
activity (Figure 2A). Across all these genes, the 
absolute magnitude of effect was doubled (net 
12% change in differentiating cells vs. 6% in 
undifferentiated cells, p < 0.02). Chlorpyrifos 
elicited significant up-regulation of cat and 
transient up-regulation of gss, effects that were 
not seen in the undifferentiated state, as well 
as eliciting much larger initial increases in gpx2 
and gpx7; for the latter, we found a signifi-
cant subsequent rebound suppression at 72 hr. 
Two additional changes resembled those seen 
in the undifferentiated cells, namely, down-
regulation of sod2 and sod3.
The response to diazinon in differentiat-
ing PC12 cells was distinctly different from 
that evoked by chlorpyrifos (Figure 2B). 
Diazinon failed to alter cat, gss, or gpx7 expres-
sion; enhanced sod2 instead of suppressing it; 
and evoked additional changes not seen with 
chlor  pyrifos, namely, increases in gpx1 and 
gpx3 and decreases in gpx6. The only point of 
clear overlap between the two agents was for 
gpx2, which showed the same transient eleva-
tion for diazinon and for chlorpyrifos. 
Dieldrin evoked some of the same 
changes as did diazinon, including up-regu-
lation of sod2 and gpx3 and down-regulation 
of gpx6 (Figure 2C). It differed in that diel-
drin reduced sod1, gpx1, and gpx4, leaving 
gpx2 unaffected. Exposure to Ni2+ produced 
a different response pattern, with small but 
significant reductions in sod1, sod2, gpx1, and 
gpx6 and a larger transient decrease in gpx2 
(Figure 2D). The only major point of conso-
nance was for gpx3, which showed the same 
type of transient increase as seen with diazi-
non and dieldrin, except that with Ni2+, it 
was followed by a decrease at 72 hr.
Glutathione S-transferases in differentiat-
ing cells. Again, the genes encoding the various 
glutathione S-transferases showed much greater 
responses to chlorpyrifos in differentiating 
PC12 cells (Figure 3A) than in undifferenti-
ated cells, with double the absolute magnitude 
of change (net 12% in differentiating cells vs. 
6% in undifferentiated cells, p < 0.03). Indeed, 
we found significant changes in expression for 
13 of the 18 genes in this group, with increases 
(10 genes) predominating over decreases 
(3 genes). The largest changes were seen for 
gsta5 (increase), gstm6 (increase), and gsto2 
(decrease). We found smaller increases for 
gstm1, gstm2, gstm4, gsto1, gstp2, gstt1, gstt2, 
and gst13-13; minor but significant decreases 
were confined to mgst3 and yc2.
For this set of genes, diazinon exposure 
altered expression in a pattern somewhat 
similar to that of chlorpyrifos, albeit with 
much smaller overall effects on the genes that 
showed the biggest changes with chlorpyrifos 
(Figure 3B). Like chlorpyrifos, diazinon evoked 
up-regulation of gsta5, gstm2, gstm4, gsto1, and 
gstt2 and down-regulation of gsto2 and mgst3. 
In addition, diazinon enhanced gsta4 and sup-
pressed gstm3, gstt3, and gst13-13, effects that 
were not seen with chlorpyrifos, while failing 
to affect many of the genes that were signifi-
cantly altered by chlorpyrifos (gstm1, gstm6, 
gstp2, gstt1, yc2). With dieldrin exposure 
(Figure 3C), we again saw features shared by 
chlorpyrifos and/or diazinon, namely, robust 
up-  regulation of gsta5; lesser stimulation of 
gstm4, gstm6, gsto1, and gstp2; and down-
  regulation of gstm3, gsto2, and gstt3. We also 
found features unique to dieldrin: a decrease 
in mgst2 and an increase in yc2 expression. 
Although exposure to Ni2+ (Figure 3D) pro-
duced some changes in gene expression resem-
bling those of the other three agents (e.g., 
decreased gsto2 expression), the overall response 
pattern was distinctly different, with inhibition 
Figure 1. Effects of 30 µM chlorpyrifos exposure in undifferentiated PC12 cells. (A) Antioxidant genes. (B) Genes encoding the glutathione S-transferases. (C) Genes 
encoding the ionotropic glutamate receptors. (D) Genes encoding the metabotropic glutamate receptors. The vertical line in (A) separates genes encoding catalase 
and the superoxide dismutase isoforms from those involved in glutathione synthesis and redox status. 
*Significant main treatment effect. †Treatment × time interaction and times for which treatment effects were present. Multivariate ANOVA (treatment, gene, time) indicates interactions 
of treatment × gene (p < 0.0001) and treatment × gene × time (p < 0.01). 
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predominating over stimulation (main treat-
ment effect, p < 0.0001). We found significant 
decreases for all but 6 of the 20 genes, and no 
individual gene showed a significant increase.
Glutamate receptors in differentiat-
ing cells. Unlike the situation with the genes 
involved in oxidative stress, chlorpyrifos expo-
sure in differentiating cells showed approxi-
mately the same net absolute response for 
glutamate receptor genes as in undifferen-
tiated cells (16% change for differentiating 
cells vs. 12% change for undifferentiated cells; 
not significant); this was also true even if the 
comparison was restricted to ionotropic glu-
tamate receptors (18% vs. 16%, respectively), 
the sub  group that participates in organo-
phosphate-induced neuro  toxicity (Chebabo 
et al. 1999; Damodaran et al. 2006; Dekundy 
Figure 2. Effects of 30 µM chlorpyrifos (A), diazinon (B), dieldrin (C), and Ni2+ (D) exposure on expression of antioxidant genes in differentiating PC12 cells. The 
vertical lines separate genes encoding catalase and the superoxide dismutase isoforms from those involved in glutathione synthesis and redox status. 
*Significant main treatment effect. †Treatment × time interaction and times for which treatment effects were present. Multivariate ANOVA (all treatments, all genes, time) indicates a 
significant main effect of treatment (p < 0.02) and interactions of treatment × gene (p < 0.0001) and treatment × gene × time (p < 0.006). 
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Figure 3. Effects of 30 µM chlorpyrifos (A), diazinon (B), dieldrin (C), and Ni2+ (D) exposure on expression of genes encoding the glutathione S-transferases in 
  differentiating PC12 cells. 
*Significant main treatment effect. †Treatment × time interaction and times for which treatment effects were present. Multivariate ANOVA (all treatments, all genes, time) indicates a 
significant main effect of treatment (p < 0.0001) and interactions of treatment × time (p < 0.001), treatment × gene (p < 0.0001), and treatment × gene × time (p < 0.0001).
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et al. 2007; Gupta 2004). However, we found 
significant differences in the response of spe-
cific genes in the differentiating versus undif-
ferentiated states (treatment × state × gene, 
p < 0.004) and in the time course of effect 
(treatment × state × gene × time, p < 0.006). 
Just as in undifferentiated cells, chlorpyrifos 
exposure during differentiation elicited signif-
icant up-regulation of gria1, gria3, grik3, and 
grina and down-regulation of gria2, gria4, and 
grin2a (Figure 4A). However, we also found 
key differences: increases in grid2, grin1, and 
grin2b and decreases in grin3b restricted to 
differentiating cells (Figure 4A); increases 
in grik4 and grik5, and decreases in grik2 
restricted to undifferentiated cells (Figure 1C); 
increases in grin3a in undifferentiated cells 
(Figure 1C) but decreases for the same gene 
in differentiating cells (Figure 4A); and dif-
ferences between undifferentiated (Figure 1C) 
and differentiating cells (Figure 4A) in the 
time course of effect for gria3 and grin2a.
Like chlorpyrifos, diazinon exposure 
altered the expression for most of the genes 
encoding ionotropic glutamate receptors 
(Figure 4B). However, the patterns of effects 
showed major disparities between the two 
organophosphates, with similar changes for 
only four genes (gria1, gria2, gria4, grina) and 
dissimilar effects for 11 genes (gria3, grid2, 
grik2, grik3, grik4, grik5, grin2a, grin2b, 
grin2d, grin3a, grin3b), even to the extent of 
changes in the opposite direction. Dieldrin 
elicited more modest changes, but in general, 
the pattern was closer to that of diazinon, 
sharing similar changes for gria1, gria2, grik3, 
grin2b, grin2c, and grina, as well as a lack 
of effect on gria3, grid2, grik1, and grin3a 
(Figure 4C); the two differed for gria4, grid1, 
grik2, grik4, and grin2a. Although exposure 
to Ni2+ elicited the same increase in gria1 
seen with the other three agents, in general it 
affected a much smaller repertoire of genes, 
with only five significant changes among 
the total of 19 (Figure 4D). Like diazinon 
or dieldrin, Ni2+ reduced the expression of 
grin2b, an effect opposite that of chlorpyrifos, 
but Ni2+ also affected grin2c (decrease), grina 
(decrease), and grin3b (increase) in a manner 
distinct from one or more of the other agents.
Although chlorpyrifos exposure in undif-
ferentiated PC12 cells did not alter the 
expression of genes encoding the metabo-
tropic glutamate receptors, differentiating 
cells were more sensitive, displaying changes 
for three of the eight subtypes (Figure 5A): 
increased grm4 and decreased grm5 and grm6. 
The effects of diazinon were totally different, 
with increases in grm1 and grm6 and a small 
but significant decrease in grm3 (Figure 5B). 
Dieldrin produced even less of an effect, 
restricted to an increase in grm6 (Figure 5C). 
Likewise, Ni2+ evoked only a transient change 
in grm4 expression (Figure 5D). Taken across 
all four agents, the incidence of changes in 
metabo  tropic glutamate receptor genes (25%) 
was much lower than for ionotropic receptors 
(50%, p < 0.01 by Fisher’s exact test).
Discussion
In earlier work with the PC12 cell model, 
we showed that lipid peroxidation evoked 
by chlor  pyrifos was enhanced by coexposure 
to NGF (Qiao et al. 2005), consistent with 
increased sensitivity to oxidative stress dur-
ing neuro  differentiation. We confirmed this 
by studies conducted in vivo with chlorpy-
rifos administered to neonatal rats, which 
likewise evoked greater lipid peroxidation in 
vulnerable brain regions during peak periods 
of axono  genesis and synapto  genesis (Slotkin 
et al. 2005). In the present study, we found 
much larger and wide  spread transcriptional 
changes elicited by chlor  pyrifos exposure in 
differentiating PC12 cells compared with 
undifferentiated cells, for genes involved in 
the oxidative stress response (cat, sod, gss, gsr, 
gpx, gst, mgst, yc2; including all subtypes); the 
correspondence of the changes in gene expres-
sion with the functional end point of lipid 
peroxidation thus serves as a validation of this 
approach. Further, genes encoding the glu-
tamate receptors did not show a correspond-
ing net increase in chlorpyrifos effects during 
differentiation, demonstrating the specificity 
for those elements directly involved in mus-
tering anti  oxidant defenses; we found selec-
tive differences for individual receptor genes 
that depended on differentiation state, but 
the overall magnitude of effect was no greater 
in differentiating cells compared with undif-
ferentiated cells, unlike the situation for anti-
oxidant genes. Indeed, for undifferentiated 
cells, the effect of chlorpyrifos on iono  tropic 
glutamate receptor genes was far more robust 
than for the genes involved in oxidative stress; 
further, this was not true for metabo  tropic 
glutamate receptors, which are not involved 
Figure 4. Effects of 30 µM chlorpyrifos (A), diazinon (B), dieldrin (C), and Ni2+ (D) exposure on expression of genes encoding the ionotropic glutamate receptors in 
differentiating PC12 cells. 
*Significant main treatment effect. †Treatment × time interaction and times for which treatment effects were present. Multivariate ANOVA (all treatments, all genes, time) indicates inter-
actions of treatment × time (p < 0.01), treatment × gene (p < 0.0001), and treatment × gene × time (p < 0.0003).
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in excito  toxicity. Our results thus suggest a 
greater role for excitotoxicity than for oxida-
tive stress in the undifferentiated state (i.e., 
earlier stages of neuro  development) but an 
increasing role for oxidative stress as cells 
undergo differentiation (later stages of neuro-
development). The comparative effects of 
chlorpyrifos in the two states thus reinforce 
the idea that both oxidative stress and excito-
toxicity are likely contributors that define the 
critical windows in which specific neuronal 
populations in the developing brain are most 
vulnerable to different aspects of chlor  pyrifos 
neurotoxicity (Garcia et al. 2005; Slotkin 
1999, 2004, 2005).
In differentiating cells, both chlorpyrifos 
and diazinon produced widespread changes 
in the expression of genes involved in oxida-
tive stress. Although we found a significant 
correlation between the effects on these genes 
for the two organophosphates (Table 2), the 
relatively modest correlation coefficient (r = 
0.40) points to substantial differences, as well. 
In fact, the effects on the primary anti  oxidant 
genes—cat and the sod subtypes—were totally 
dissimilar, as evidenced by a strong negative 
correlation between chlor  pyrifos and diazinon 
(Table 2); this reflected not only an oppo-
site direction of change for sod2 but also a 
substantially greater overall effect of chlorpy-
rifos across this set of genes (average change 
11% for chlor  pyrifos vs. 4% for diazinon, 
p < 0.02). These results point to the likeli-
hood that chlor  pyrifos either produces a 
greater degree of oxidative stress or, through 
its other mecha  nisms of action, exacerbates 
the net effect of oxidative stress. In contrast, 
our results for the glutathione-related genes 
suggest a similar outcome from the two 
agents, evidenced by a significant positive 
correlation (Table 2); the larger number of 
glutathione-related genes also accounts for the 
overall concordance between chlorpyrifos and 
diazinon across all the oxidative-stress–related 
genes and points to why examination of sub-
divisions is important to delineate different 
mechanisms and potential outcomes. Indeed, 
despite the positive correlation for the gluta-
thione-related genes, individual components 
in that set displayed markedly different effects 
of the two agents (e.g., gpx6 and gstm6).
The much more widespread and robust 
effects of chlorpyrifos on expression of ion-
otropic glutamate receptors compared with 
metabotropic receptors in differentiating PC12 
cells reflects the specific involvement of these 
receptors in the excitotoxicity associated with 
organophosphate-induced neuronal injury 
(Damodaran et al. 2006; Gupta 2004) and are 
similar to results reported previously for effects 
on the developing rat brain after neo  natal chlor-
pyrifos exposure (Slotkin and Seidler 2007). 
Here, although diazinon likewise produced 
widespread effects on iono  tropic glutamate 
Figure 5. Effects of 30 µM chlorpyrifos (A), diazinon (B), dieldrin (C), and Ni2+ (D) exposure on expression of genes encoding the metabotropic glutamate receptors 
in differentiating PC12 cells. 
*Significant main treatment effect. †Treatment × time interaction and times for which treatment effects were present. Multivariate ANOVA (all treatments, all genes, time) indicates inter-
actions of treatment × time (p < 0.05) and treatment × gene (p < 0.02).
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Table 2. Concordance between test agents.
  Chlorpyrifos  Chlorpyrifos  Chlorpyrifos  Diazinon  Diazinon  Dieldrin
  vs. diazinon  vs. dieldrin  vs. Ni2+  vs. dieldrin  vs. Ni2+  vs Ni2+
All oxidative stress- and  r = 0.40  r = 0.37  r = 0.11  r = 0.62  r = 0.20  r = 0.30
  glutathione-related genesa  p < 0.001  p < 0.003  NS  p < 0.0001  NS  p < 0.02
cat, sod  r = –0.66  r = –0.62  r = 0.53  r = 0.51  r = –0.52  r = –0.08
  p < 0.05  p < 0.05  NS  NS  NS  NS
All glutathione-related genes  r = 0.46  r = 0.43  r = 0.13  r = 0.63  r = 0.22  r = 0.31
  p < 0.0004  p < 0.002  NS  p < 0.0001  NS  p < 0.03
All glutamate receptor genes  r = 0.02  r = 0.02  r = 0.03  r = 0.58  r = 0.23  r = 0.56
  NS  NS  NS  p < 0.0001  NS  p < 0.0001
Ionotropic glutamate receptors  r = 0.05  r = 0.06  r = 0.02  r = 0.59  r = 0.25  r = 0.60
  NS  NS  NS  p < 0.0001  NS  p < 0.0001
Metabotropic glutamate receptors  r = 0.09  r = –0.37  r = –0.02  r = 0.60  r = 0.05  r = 0.31
  NS  NS  NS  p < 0.02  NS  NS
All genes  r = 0.20  r = 0.18  r = 0.04  r = 0.60  r = 0.21  r = 0.42
  p < 0.04  p < 0.05  NS  p < 0.0001  p < 0.03  p < 0.0001
NS, not significant.
aAll genes in the cat, sod, gss, gsr, gpx, and gst families.Slotkin and Seidler
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receptors, the overall pattern was totally dis-
tinct from that of chlorpyrifos, evidenced by a 
lack of concordance whether considering each 
receptor class separately or together (Table 2). 
Again, this is consistent with major differences 
between the two agents observed for expres-
sion of the same receptor genes after in vivo 
exposures (Slotkin and Seidler 2007). One 
likely reason is that chlor  pyrifos may inter-
act directly with ion channel receptors that 
gate calcium entry (Katz et al. 1997; Smulders 
et al. 2004). Because this mechanism obviously 
reflects actions unrelated to the shared property 
of cholinesterase inhibition, the structural dif-
ferences between chlorpyrifos and diazinon 
could clearly contribute to dissimilar effects on 
ionotropic glutamate receptor function, leading 
to disparities in receptor expression.
Perhaps the most surprising result is the 
close similarity between the outcomes of 
exposure to dieldrin and those of diazinon. 
We found high concordance between these 
two agents across the oxidative-stress–related 
genes as well as the glutamate receptor genes, 
resulting in a substantially higher correla-
tion across all genes than for chlor  pyrifos and 
diazinon, the two organophosphates (Table 2). 
This was also reflected in the lesser correlations 
between chlorpyrifos and dieldrin, which were 
just as robust as those between chlorpyrifos 
and diazinon (Table 2). In our earlier work 
with PC12 cells, we similarly found conver-
gent outcomes for diazinon and dieldrin on 
lipid peroxidation and on differentiation end 
points, including indices of neurite formation 
and neuro  transmitter pheno  type (Slotkin et al. 
2007b; Slotkin and Seidler 2008, 2009). Our 
present findings can thus guide future studies 
of in vivo dieldrin exposure to confirm the pre-
diction that this agent will produce develop-
mental neurotoxicity akin to that of diazinon.
Ni2+ does not evoke oxidative stress 
(Slotkin et al. 2007b), and accordingly, this 
agent elicited changes in gene expression that 
were distinct from those of the organophos-
phates. We found no significant concordance 
in the outcomes for chlor  pyrifos compared 
with Ni2+ and only a weak overall correlation 
for diazinon and Ni2+ that did not achieve 
significance for any subset of genes (Table 2). 
The difference between Ni2+ and the pesticides 
is best illustrated by comparing effects on the 
gluta  thione S-transferases, where the metal 
produced widespread down-regulation com-
pared with the predominance of up-regulation 
for three pesticides. Further, the fact that all 
four agents (including Ni2+) down-regulated 
gsto2 indicates that this particular transcrip-
tional change is probably not involved in the 
response to oxidative stress per se. We found 
a significant overall concordance for dieldrin 
and Ni2+, primarily reflecting their shared 
actions on glutamate receptors. Interestingly, 
although we found concordance between 
dieldrin and Ni2+ and between diazinon and 
dieldrin for the ionotropic glutamate recep-
tors, the correlation was much poorer between 
dieldrin and Ni2+; this points out that the con-
cordance patterns between any two agents can 
involve sets of genes different from those gen-
erating the concordance between one of those 
agents and a third compound. In any case, 
the unexpected similarities between appar-
ently unrelated neurotoxicants in their effects 
on ionotropic glutamate receptors points to 
future experiments on the potential for con-
vergent underlying mechanisms and outcomes 
involving excitotoxicity.
The limitations and advantages of the 
combination of in vitro model and planned 
comparison approaches to micro  array data 
have been detailed in earlier work (Slotkin 
et al. 2007c, 2008d, 2008e; Slotkin and 
Seidler 2007, 2008) but are worth repeating 
in relation to the present study. We used cells 
from a transformed cell line, which, unlike 
primary neurons in culture, maintain their 
ability to divide, an important consideration 
when, as here, the neuro  toxicants target 
the cell cycle as part of their injury pattern. 
Nevertheless, transformed cells are inherently 
less sensitive to toxicant injury than are devel-
oping neurons in vivo. Further, cell culture 
treatments involve much shorter durations 
than with environmental exposures extending 
throughout brain develop  ment. We consid-
ered both of these factors in our selection of 
the 30 µM test concentrations. In the case of 
the organophosphates, this is approximately 
an order of magnitude higher than the lev-
els in newborn babies after nonsymptomatic 
environmental exposures in agricultural com-
munities (Ostrea et al. 2002); however, the 
cultures contain high concentrations of serum 
proteins, so < 10% of the nominal concentra-
tion is actually available to diffuse into the 
cells (Qiao et al. 2001). The most important 
proof of relevance, however, is that for chlo-
rpyrifos and diazinon, parallel outcomes have 
been identified between in vivo exposures and 
the PC12 model (Bagchi et al. 1995, 1996; 
Crumpton et al. 2000a, 2000b; Das and 
Barone 1999; Flaskos et al. 1994; Jameson 
et al. 2006, 2007; Li and Casida 1998; Nagata 
et al. 1997; Qiao et al. 2001, 2005; Slotkin 
et al. 2007a, 2007b, 2008d, 2008e; Song et al. 
1998; Tuler et al. 1989), thus providing vali-
dation of the in vitro approach. The second 
factor in these studies is our use of planned 
comparisons, a distinctly different approach 
from the global examination of the tens of 
thousands of genes present on the microar-
rays. Planned comparisons are based on test-
ing a specific hypothesis that centers around 
a defined set of gene families and rests on 
known, validated outcomes from prior work, 
in this case involving both in vivo and in vitro 
demonstrations of oxidative stress from the 
organophosphates. With examination of the 
entire genome, verification via reverse tran-
scriptase polymerase chain reaction and other 
techniques is required because the enormous 
number of comparisons generates numerous 
false-positive findings (e.g., the > 2,000 genes 
that would be false positives if we had consid-
ered all 42,000 probes on the array). For our 
study, we compared only a handful of genes 
that would generate only three false positives, 
and we found alterations in most of these 
genes; for interpretation, we relied on mul-
tiple gene changes in a given pathway, as well 
as effects that repeated across different treat-
ments and/or different time points, rather 
than changes in any one gene. The odds of 
all those genes being false positives are astro-
nomically small. However, even for individual 
genes, a given array used multiple probes and 
multiple spots (see “Materials and Methods”), 
so the changes cannot be “chance.” Unlike 
many array studies, where a single mRNA set 
derived from multiple samples might be eval-
uated, we evaluated up to eight separate sam-
ples for each treatment condition, so again, 
it is inconceivable statistically that we could 
produce these outcomes by accident. Indeed, 
one of the key points of this study is to dem-
onstrate that a planned comparison approach 
may provide a superior strategy for the use of 
microarray data, provided that the relevant 
target pathways are known in advance.
In conclusion, our findings reinforce the 
growing body of evidence that the various 
organo  phosphates differ in their underlying 
mechanisms of developmental neuro  toxicity, 
over and above their shared property as cho-
linesterase inhibitors, culminating in distinct 
outcomes at the levels of synaptic function 
(Jameson et al. 2007; Qiao et al. 2001; 
Roegge et al. 2008; Slotkin et al. 2006a, 
2006b, 2007b, 2007c, 2008a, 2008b, 2008c, 
2008d; Slotkin and Seidler 2007; Timofeeva 
et al. 2008a, 2008b). As shown here, these 
mechanisms are likely to include selective 
effects on oxidative stress and excitotoxicity, 
as well as enhanced vulnerability to oxida-
tive stress during a critical period centered 
around differentiation into neurotransmitter 
phenotypes and the development of neuritic 
projections. At the same time, the concor-
dance of overall effects between diazinon and 
dieldrin, and for effects of dieldrin and Ni2+ 
on glutamate receptors, indicate that agents 
from apparently unrelated classes of toxicants 
can nonetheless converge on common final 
outcomes, despite differences in underlying 
targets or originating mechanisms. Finally, 
the results obtained here illustrate how 
a combined use of cell culture systems and 
microarrays can guide future studies toward 
specific end points that can distinguish simi-
larities and disparities in the effects of diverse 
develop  mental neurotoxicants.Mechanisms of developmental neurotoxicants
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